TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,256
|
2,116
|
691 |
| Financial expenses |
2
|
0
|
1 |
| Earnings before taxes |
-163
|
209
|
-677 |
| EBITDA |
-152
|
214
|
-673 |
| Total assets |
9,022
|
9,146
|
9,941 |
| Current assets |
2,145
|
3,235
|
4,382 |
| Current liabilities |
612
|
646
|
922 |
| Equity capital |
8,410
|
8,500
|
9,019 |
| - share capital |
242
|
241
|
263 |
| Employees (average) |
13
|
10
|
9 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
93.2%
|
92.9%
|
90.7% |
| Turnover per employee |
174
|
212
|
77 |
| Profit as a percentage of turnover |
-7.2%
|
9.9%
|
-98.0% |
| Return on assets (ROA) |
-1.8%
|
2.3%
|
-6.8% |
| Current ratio |
350.5%
|
500.8%
|
475.3% |
| Return on equity (ROE) |
-1.9%
|
2.5%
|
-7.5% |
| Change turnover |
133
|
1,482
|
329 |
| Change turnover % |
6%
|
233% | |
| Chg. No. of employees |
3
|
1
|
1 |
| Chg. No. of employees % |
30%
|
11% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.